| Identification | Back Directory | [Name]
Zatosetron Maleate | [CAS]
123482-23-5 | [Synonyms]
Zatosetron Maleate
5-Chloro-2,3-dihydro-2,2-dimethyl-N-[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3α-yl]benzofuran-7-carboxamide·maleic acid | [Molecular Formula]
C23H29ClN2O6 | [MDL Number]
MFCD00866225 | [MOL File]
123482-23-5.mol | [Molecular Weight]
464.939 |
| Hazard Information | Back Directory | [Originator]
Zatosetron
maleate,Eli-Lilly | [Uses]
Antimigraine. | [Manufacturing Process]
A mixture of 5-chloromethyl salicylate, 3-chloro-2-methylpropene, potassium
carbonate, and acetone was heated at reflux overnight. After cooling, the
mixture was extracted with diethyl ether and ethyl acetate. The organic
extracts were combined, washed twice with a 10% sodium chloride solution
and water, dried over sodium sulfate, and concentrated in vacuum. The
resulting liquid was vacuumed distilled. The fraction collected and the desired
5-chloro-2-(2-methyl-2-propenyloxy)benzoic acid, methyl ester was obtained.
The 5-chloro-2-(2-methyl-2-propenyloxy)benzoic acid, methyl ester was
heated at reflux for 6 h in 1-methyl-2-pyrrolidinone. The mixture was then
vacuum distilled and the fraction collected and the desired 2-hydroxy-5-
chloro-3-(2-methyl-2-propenyl)benzoic acid, methyl ester was obtained.
A mixture of the 2-hydroxy-5-chloro-3-(2-methyl-2-propenyl)benzoic acid,
methyl ester and 1 L of methanol was saturated with 90% formic acid and
then refluxed overnight. The solution was concentrated in vacuum, added to
water, and extracted with ethyl acetate. The organic layer was washed with
water, dried over sodium sulfate, and concentrated in vacuum, providing the
desired 2,2-dimethyl-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid,
methyl ester as an oil.
The 2,2-dimethyl-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, methyl
ester were heated at reflux with sodium hydroxide and water for 2-3 h. After
cooling, the mixture was extracted with diethyl ether and ethyl acetate. The
aqueous layer was acidified with hydrochloric acid and again extracted with
ethyl acetate and diethyl ether. These latter organic extracts were combined
and washed with water, dried over sodium sulfate, and concentrated in
vacuum. Crystallization of the resulting solid from ethyl acetate/hexane
provided the desired 2,2-dimethyl-5-chloro-2,3-dihydrobenzofuran-7-
carboxylic acid, 71% yield, melting point 158.5°-160°C.
A mixture of 2,2-dimethyl-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid
and thionyl chloride was heated at reflux for 3 h. After the mixture was
3522 Zatosetron maleate
concentrated in vacuum and azeotroped with toluene, dry toluene was added
and the solution cooled to 5°C. A solution of N-methyl-tropamine in toluene
was added in dropwise fashion and the reaction heated at reflux overnight.
After cooling, the mixture was added to ice water, made basic, and extracted
with diethyl ether/ethyl acetate. The organic layer was washed twice with 6 N
hydrochloric acid. The combined aqueous extracts were cooled, made basic
with sodium hydroxide solution, and extracted with ethyl acetate. The ethyl
acetate solution was washed twice with water, dried over sodium sulfate, and
concentrated in vacuum providing of the endo-5-chloro-2,3-dihydro-2,2-
dimethyl-N-(8-methyl-8-azabicyclo[3.2.1.]oct-3-yl-7-benzofurancarboxamide,
free base, as an oil.
In practice it is usually used as maleate salt. | [Therapeutic Function]
Serotonin antagonist | [in vivo]
Acute administration of 0.1 (n=21) and 0.3 (n=5) mg/kg Zatosetron maleate (Zatosetron) in male rats, but not 0.01, 0.05, 1.0 or 10 mg/kg (n=5, 3, 6 and 4, respectively) Zatosetron maleate or saline (n=5), leads to a significant reduction in the number of spontaneously active A10 dopamine cells. The number of spontaneously active A10 dopamine cells is not significantly different from 30 to 60 min post i.p. Zatosetron maleate (0.1 mg/kg) administration, shows a significant decrease by 60 to 90 min (0.65±0.11, P=0.03, n=5), a larger decrease by 90 to120 min (0.53±0.08, P=0.004, n=5) and remains at this significantly decreased level from 2 to 3 h (0.50+0.05, P=0.0004, n=5). Single-unit recordings show that Zatosetron maleate inhibits the activity of A10 dopamine cells following i.v. administration (ED50=0.12 mg/kg, n=8). Chronic administration of 0.1 mg/kg (n=16) Zatosetron maleate, but not 0.01, 1.0 or 10 mg/kg (n=4, 8 and 7, respectively) Zatosetron maleate or saline (n=5), leads to a significant reduction in the number of spontaneously active A10 dopamine cells[2]. | [IC 50]
5-HT3 Receptor | [storage]
Store at -20°C |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|